亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Lenvatinib delivery using a Gd/Fe bimetallic MOF: Enhancing antitumor immunity following microwave-based thermal therapy

癌症研究 材料科学 肿瘤微环境 医学 佐剂 免疫疗法 体内 肿瘤科 癌症 内科学 生物 肿瘤细胞 生物技术
作者
Qiaozheng Wang,Xiaowen Zhu,Xianwei Meng,Hongshan Zhong
出处
期刊:Acta Biomaterialia [Elsevier BV]
卷期号:172: 382-394 被引量:13
标识
DOI:10.1016/j.actbio.2023.09.052
摘要

Microwave (MW) thermal therapy has been developed as an effective clinical strategy that can achieve pronounced antitumor activity and also has the potential to trigger antitumor immunity. However, patients generally face high rates of tumor recurrence following MW treatment, limiting the long-term benefits of such treatment. The combination of MW treatment and immunomodulatory strategies may represent a promising means of reprogramming the immunosuppressive tumor microenvironment (TME) in a manner conducive to lower recurrence rates. In this study, a Lenvatinib-loaded Gd/Fe metal-organic framework (Gd/FeMOF) was designed as a promising approach to enhancing such antitumor immunity. MW-enhanced dynamic Gd/FeMOF sensitization can facilitate high levels of reactive oxygen species production under MW irradiation, resulting in stronger immunogenic tumor cell death. In parallel, the Lenvatinib released from Gd/FeMOF preparations can serve as an immune adjuvant that suppresses programmed death ligand 1 (PD-L1) expression and drives the reprogramming of the immunosuppressive TME. The Gd and Fe present within this MOF preparation also imbue it with magnetic resonance imaging capabilities. Importantly, in vivo animal model experiments confirmed the ability of GdFeMOF treatment to significantly enhance antitumor immunity while protecting against recurrence. Accordingly, this study offers a foundation for promising strategies aimed at the integrated diagnosis and durable treatment of cancer. STATEMENT OF SIGNIFICANCE: High rates of tumor recurrence following MW thermal therapy limit the long-term benefits of such treatment. We found that the administration of Lenvatinib-loaded Gd/FeMOF nanoparticles significantly reduced tumor recurrence after MW thermal therapy. Under MW irradiation, the Gd/FeMOF nanoparticles were found to augment the immune response due to facilitation of the process of immunogenic cell death. In addition, the released Lenvatinib could act as an immune adjuvant to downregulate the expression of PD-L1 and reprogram the immunosuppressive state of the tumor microenvironment, thus further enhancing the immune response. This is significant because MW-induced immune responses are relatively weak and usually fail to effectively prevent tumor recurrence. The combination of MW treatment with an immunomodulatory strategy may solve this problem.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
桐桐的应助被初景采纳,获得10
刚刚
科研通AI6.3的应助被yinian采纳,获得100
4秒前
朝花惜拾完成签到 ,获得积分10
8秒前
直率的晓亦完成签到,获得积分10
10秒前
汉堡包的应助被白丶魈白采纳,获得10
11秒前
15秒前
贺知什么书完成签到,获得积分10
15秒前
Saturday完成签到,获得积分10
16秒前
yx完成签到,获得积分10
16秒前
义气的夏旋完成签到,获得积分10
17秒前
19秒前
ku完成签到 ,获得积分10
22秒前
23秒前
23秒前
Noob_saibot完成签到,获得积分10
25秒前
aa完成签到 ,获得积分10
25秒前
初景发布了新的文献求助10
29秒前
白丶魈白完成签到,获得积分10
31秒前
31秒前
32秒前
kl完成签到,获得积分10
32秒前
SciGPT的应助被花痴的文涛采纳,获得10
33秒前
清新的初雪完成签到 ,获得积分10
35秒前
传奇3的应助被streetlight采纳,获得10
35秒前
木棉发布了新的文献求助10
36秒前
Able发布了新的文献求助10
36秒前
大色国君完成签到 ,获得积分10
38秒前
39秒前
LiuSD完成签到,获得积分10
39秒前
简单的语风完成签到,获得积分10
40秒前
木棉完成签到,获得积分10
44秒前
无花果的应助被白丶魈白采纳,获得10
46秒前
49秒前
49秒前
耳朵在安上完成签到 ,获得积分10
50秒前
52秒前
玛卡巴卡发布了新的文献求助10
53秒前
孤独怀寒完成签到,获得积分10
53秒前
美好的泽洋完成签到 ,获得积分10
54秒前
luo发布了新的文献求助10
56秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8195028
求助须知:如何正确求助?哪些是违规求助? 9580753
关于积分的说明 21872602
捐赠科研通 7794788
什么是DOI,文献DOI怎么找? 3437855
关于科研通互助平台的介绍 2561176
邀请新用户注册赠送积分活动 2484562